Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 3

1.25 CME
1.00 COPE
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Provider Statement: This continuing education activity is provided by Purdue U

Educational Partner:  Vindico Medical Education

Support Statement: This activity is supported by an educational grant from Shire.

Target Audience: The intended audience for the activities is ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with ocular surface disorders.

Learning Objectives:

Upon successful completion of this publication series, participants should be better able to:

  • Evaluate risk factors and diagnostic modalities for ocular surface disease to facilitate prompt identification and diagnosis.
  • Describe the effects that ocular surface disease is known to have on surgical outcomes.
  • Assess treatment strategies that provide optimal outcomes according to the etiology and severity of the ocular surface disease.

Chief Medical Editor:
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC

Associate Medical Editor:
Paul M. Karpecki, OD, FAAO
Director, Cornea Services
Kentucky Eye Institute
Lexington, KY

Editorial Board Members:
Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA

Marjan Farid, MD
Associate Professor of Ophthalmology
Director of Cornea, Refractive, and Cataract Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

Preeya K. Gupta, MD
Assistant Professor of Ophthalmology
Cornea, Cataract, and Refractive Surgery
Duke University Eye Center
Durham, NC

Christopher E. Starr, MD, FACS
Associate Professor of Ophthalmology
Director, Refractive Surgery Service
Director, Cornea Fellowship
Director, Ophthalmic Education
Weill Cornell Medical College
New York Presbyterian Hospital
New York, NY

Guest Contributors:
John J. DeStafeno, MD
Partner, Chief Operating Officer
Chester County Eye Care Associates
West Chester, PA
Clinical Instructor of Ophthalmology
Wills Eye Hospital
Philadelphia, PA

Kristen L. Epting, OD, FAAO
Eye Care Specialists
Kingston, PA

Thomas "TJ" John, MD
Clinical Associate Professor
Loyola University at Chicago
Chicago, IL
Private Practice
Oak Brook, IL; Tinley Park, IL; and Oak Lawn, IL

Tal Raviv, MD, FACS
Associate Clinical Professor of Ophthalmology
Icahn School of Medicine at Mount Sinai
Adjunct Surgeon, Dept. of Ophthalmology/Cornea
New York Eye and Ear Infirmary of Mount Sinai
Founder and Medical Director
Eye Center of New York
New York, NY

Steve Abel, PharmD, FASHP
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Purdue University is approved by the Council on Optometric Practitioner Education (COPE) as an administrator/provider of continuing education (CE).

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
This enduring material is COPE-accredited for 1.0 continuing education credits and is approved for one (1) year from the date of original release, November 1, 2017 to October 31, 2018.

COPE ID #: 55462-AS
COPE Event #: 114479

Please consult your state’s Board of Optometry to determine if the CE/CME credit may apply toward your CE/CME requirement for license renewal.

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How To Participate in this Activity and Obtain CE/CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category (1) Credit(s)TM certificate.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, reviewers, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Editorial Board and Faculty Members report the following relationships:
Brandon D. Ayres, MD
Consulting Fee: Alcon, Allergan, Shire, TearLab
Speakers Bureau: Alcon, Allergan, Bausch + Lomb, Bio Tissue, Shire

John J. DeStafeno, MD
No relevant financial relationships to disclose.

Kristen L. Epting, OD, FAAO
Consulting Fee: Allergan
Speakers Bureau: Allergan

Marjan Farid, MD
Consulting Fee: Allergan, Johnson & Johnson Vision, Shire, Sightlife Surgical

Preeya K. Gupta, MD
Consulting Fee: Alcon, Allergan, Aurea, BioTissue, Johnson & Johnson Vision, Novabay, Ocular Science, Shire

Thomas John, MD
Royalty: ASICO, Jaypee Medical Publishers
Consulting Fee: Bausch + Lomb, Bio-Tissue
Speakers Bureau: Allergan, Bausch + Lomb, Bio-Tissue
Ownership Interest: Bio-Tissue

Paul M. Karpecki, OD, FAAO
Consulting Fee: Abbott Medical Optics, Aerie Pharmaceuticals, Alcon, Allergan, Akorn, Anthem, Avedro, Avellino, Bausch + Lomb, Beaver Visitech, Bio-Tissue, BlephEx, Bruder Healthcare, Cambium Pharma, Candor Pharma, Essilor, eyeBrain, Eyes4Lives, Focus Labs, Glaukos, iCare USA, Imprimis, Katena, Konan Medical, Lubris, Oculus, Ocusoft, Ocular Therapeutix, Optometric Medical Solutions, Paragon Bioteck, PECAA, Perrigo, Quark Pharmaceuticals, Reichert, Rendia, RxSight, Science Based Health, Sentiss Pharma, Shire, Sun Pharma, Tearfilm Innovations, TearLab, TearScience, TelScreen, Topcon, Vision Care, Visiometrics

Terry Kim, MD
Consulting Fee: Acucela, Aerie Pharmaceuticals, Alcon/Novartis, Allergan/Actavis, Avellino Labs, B&L/Valeant, Blephex, CoDa/Ocunexus Therapeutics, Foresight Biotherapeutics, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Ocular Systems Inc/Sightlife, Ocular Therapeutix, Oculeve Inc, Omeros, Powervision, Presbyopia Therapies, Shire, TearLab, TearScience
Ownership Interest: NovaBay Pharmaceuticals, Ocular Therapeutix, Omeros, TearScience

Tal Raviv, MD, FACS
Consulting Fee: Glaukos, Johnson & Johnson Vision, Ocular Therapeutix
Speakers Bureau: Shire

Christopher E. Starr, MD, FACS
Consulting Fee: Alcon, Allergan, Bausch + Lomb, Innovision Labs, Refocus, RPS, Shire, Sun Pharma, TearLab
Speakers Bureau: Alcon, Allergan, Bausch + Lomb
Ownership Interest: Innovision Labs, TearLab

Reviewers report the following relationships:
Steve Abel, PharmD, FASHP
Advisory Board Member: TechPoint, Indianapolis

Ronald A. Codario, MD, FACP, RPVI, CHCP
No relevant financial relationships to disclose.

Purdue University and Vindico Medical Education staff report the following relationships:
No relevant financial relationships to disclose.

Signed disclosures are on file at Purdue University and Vindico Medical Education.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University and Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME/COPE Questions?
Contact us at:
Purdue University: cmemda@purdue.edu or 765-496-1306
Vindico Medical Education: cme@vindicocme.com or 856-994-9400, ext. 504